Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021: Difference between revisions

From GxPlex

Jump to: navigation, search
Migrate to Template:DocumentData for PageForms (GxPlexBot)
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot)
 
Line 16: Line 16:
|contributors=
|contributors=
}}
}}
<noinclude>
== References ==
{| class="wikitable"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 -]] || G || - || DE || Ergänzende Empfehlungen des BfArM und des PEI zur Europäischen Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic […] Unabhängig von der gewählten Methode für ...
|}
</noinclude>

Latest revision as of 14:15, 16 July 2026


Document information
Reference DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4

04-Feb-2021

Validity area DEU
Scope(s) G
Document name Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19
Version / Revision v4

04-Feb-2021

Status Current
Document type Official recommendation
Language(s) DE
Description Ergänzende Empfehlungen des BfArM und des PEI zur Europäischen Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic, Version 4
Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 -G-DEErgänzende Empfehlungen des BfArM und des PEI zur Europäischen Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemi…